PDGFRA and telomere syndrome: In this study, we explore the in vivo efficacy of olaratumab in patient-derived xenograft (PDX) models of different STS subtypes, aiming at a better understanding of the biological changes and antitumor effects upon PDGFRA-targeted treatment in STS.